Keywords
Collagen
Controlled release
Drug encapsulation
Drug entrapment
Scanning electron microscopy
In vivo studies
Wound healing
Wound infections
Ciprofloxacin
Submitted : 2024-08-11
Accepted : 2024-08-26
Published : 2024-09-10
Abstract
In this paper, the developed microsphere-incorporated collagen scaffold presents a promising solution for delivering drugs over wound surfaces in a uniform and sustained manner. The biomaterials utilized in this system are of natural origin, minimizing potential toxicity from core materials, and collagen and gelatin exhibit active wound-healing properties. The collagen scaffold used for the delivery device offers several advantages, including minimizing dressing frequency, facilitating easier examination, and providing added aesthetic value. Furthermore, the protein-based biomaterial scaffold acts as a template for the extracellular matrix in the skin, enhancing the maturation of wounds and enabling the transition to the accelerated production of mature and aligned collagen fibers. The controlled release of antimicrobial drugs through denatured collagens and gelatin microspheres, as well as the efficient healing observed in in vivo studies, demonstrate the potential of this system for effective wound care. Overall, the incorporation of ciprofloxacin-loaded microspheres in porous collagen scaffold offers sustained releases of ciprofloxacin in infected environments, as supported by histological examination showing well-formed epidermis and dermis in the connective tissue of the skin. The system’s ability to heal full-thickness wounds within a significantly shorter time frame compared to antibiotic-incorporated collagen sponges further emphasizes its efficacy in wound healing.
References
Gonzalez ACDO, Costa TF, Andrade ZDA, et al., 2016, Wound Healing-A Literature Review. Anais Brasileiros de Dermatologia, 91(5): 614–620.
Ruszczak Z, 2003, Effect of Collagen Matrices on Dermal Wound Healing. Advanced Drug Delivery Reviews, 55(12): 1595–1611.
Singer AJ, Clark RA, 1999, Cutaneous Wound Healing. New England Journal of Medicine, 341(10): 738–746.
Gushiken LFS, Beserra FP, Bastos JK, et al., 2021, Cutaneous Wound Healing: An Update from Physiopathology to Current Therapies. Life, 11(7): 665.
Guo SA, DiPietro LA, 2010, Factors Affecting Wound Healing. Journal of dental research, 89(3): 219–229.
Robson MC, 1997, Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria. Surgical Clinics of North America, 77(3): 637–650.
Singh S, Young A, McNaught CE, 2017, The Physiology of Wound Healing. Surgery (Oxford), 35(9): 473–477.
Murphy PS, Evans GR, 2012, Advances in Wound Healing: A Review of Current Wound Healing Products. Plastic Surgery International, 2012(1): 190436.
Kreikemeyer B, Klenk M, Podbielski A, 2004, The Intracellular Status of Streptococcus pyogenes: Role of Extracellular Matrix-Binding Proteins and Their Regulation. International journal of medical microbiology, 294(2–3): 177–188.
Leaper D, Assadian O, Edmiston CE, 2015, Approach to Chronic Wound Infections. British Journal of Dermatology, 173(2): 351–358.
Williams M, 2021, Wound Infections: An Overview. British Journal of Community Nursing, 26(Sup6): S22–S25.
Sawyer RG, Pruett TL, 1994, Wound Infections. The Surgical Clinics of North America, 74(3): 519–536.
Kirubanandan S, Dhinakaran M, Hariharan NM, et al., 2022, Triphala as a Therapeutic Agent for Infected Dermal Wound Healing Processes. Int J Adv Biochem Res, 6(1): 13–36.
Kirubanandan S, Ravi B, Renganathan S, 2015, An Original Research Article on Enzyme Inhibition and Antimicrobial Potential of Triphala Against Pseudomonas aeruginosa. Journal of Medicinal Plants Studies, 3(5): 38–41.
Kirubanandan S, Renganathan S, 2015, Evaluation of Antimicrobial Potential of Aqueous and Alcoholic Extract of Triphala Against Wound Pathogens. J Med Plants Stud, 3(6): 56–59.
Kirubanandan S, 2006, Triphala Incorporated Collagen Scaffold with Sustained Release for Dermal Wound Healing in Rat, M. Tech Dissertation, Centre for Biotechnology, Anna University, Chennai-25.
Kirubanandan S, 2005, Novel Collagen Scaffold for Controlled Delivery of Triphala, M. Tech Dissertation, Centre for Biotechnology, Anna University, Chennai-25.
Chi HL, Singala A, Lee Y, 2006, Biomedical Applications of Collagen. International Journal of Pharm, (221): 1–22.
Loke WK, Lau SK, Yong LL, et al., 2004, Wound Dressing with Sustained Anti-Microbial Capability. J Biomed Mater Res, (53): 8.
Miyata T, Taira T, Noishiki Y, 1992, Collagen Engineering for Biomaterial Use. Clin. Mater, (9): 139.
Shanmugasundaram N, Sundaraseelan J, Uma S, et al., 2006, Design and Delivery of Silver Sulfadiazine from Alginate Microspheres-Impregnated Collagen Scaffold. Biomed Mater Res Part B: Appl Biomater, 77B(2006): 378.
Pachence JM, 1996, Collagen Based Devices for Soft Tissue Repair. J Biomed Mater Res Part B: Appl Biomaterials, 33(1996): 35.
Saravanan M, Bhaskar K, Maharajan G, et al., 2004, Ultrasonically Controlled Release and Targeted Delivery of Diclofenac Sodium Via Gelatin Magnetic Microspheres. International Journal of Pharmaceutics, 283(2004): 71–82.
Sripriya R, Kumar MS, Ahmed MR, et al., 2007, Collagen Bilayer Dressing with Ciprofloxacin, an Effective System for Infected Wound Healing, J Biomater Sci Polym Ed, 18(3): 335.
Sripriya R, Kumar MS, Sehgal PK, 2004, Improved Collagen Bilayer Dressing for the Controlled Release of Drugs. J. Biomed. Mater. Res. B. Appl. Biomater., 70(2): 389.
Badylak SF, 2007, The Extracellular Matrix as a Biologic Scaffold Material. Biomaterials, 28(25): 3587–3593.
Cao H, Chen MM, Liu Y, et al., 2015, Fish Collagen-Based Scaffold Containing PLGA Microspheres for Controlled Growth Factor Delivery in Skin Tissue Engineering. Colloids and Surfaces B: Biointerfaces, (136): 1098–1106.
Kim SS, Gwak SJ, Choi CY, et al., 2005, Skin Regeneration Using Keratinocytes and Dermal Fibroblasts Cultured on Biodegradable Microspherical Polymer Scaffolds. J Biomed Mater Res B Appl Biomater, 75(2): 369–377.
Li W, Lan Y, Guo R, et al., 2015, In Vitro and In Vivo Evaluation of a Novel Collagen/Cellulose Nanocrystals Scaffold for Achieving the Sustained Release of Basic Fibroblast Growth Factor. Journal of Biomaterials Applications, 29(6): 882–893.
Liu H, Fan H, Cui Y, et al., 2007, Effects of the Controlled-Released Basic Fibroblast Growth Factor from Chitosan-Gelatin Microspheres on Human Fibroblasts Cultured on a Chitosan-Gelatin Scaffold. Biomacromolecules, 8(5): 1446–1455.
Mirdailami O, Soleimani M, Dinarvand R, et al., 2015, Controlled Release of rhEGF and rhbFGF from Electrospun Scaffolds for Skin Regeneration. Journal of Biomedical Materials Research Part A, 103(10): 3374–3385.
Seland H, Gustafson CJ, Johnson H, et al., 2011, Transplantation of Acellular Dermis and Keratinocytes Cultured on Porous Biodegradable Microcarriers into Full-Thickness Skin Injuries on Athymic Rats. Burns, 37(1): 99–108.
Wang F, Wang M, She Z, et al., 2015, Collagen/Chitosan Based Two-Compartment and Bi-Functional Dermal Scaffolds for Skin Regeneration. Materials Science and Engineering: C, (52): 155–162.
Huang S, Lu G, Wu Y, et al., 2013, Mesenchymal Stem Cells Delivered in a Microsphere-Based Engineered Skin Contribute to Cutaneous Wound Healing and Sweat Gland Repair. Journal of Dermatological Science, 66(1): 29–36.
Shanmugam K, Subha V, Renganathan S, 2019, Type 1 Collagen Scaffold Functionalized with Ciprofloxacin Loaded Gelatin Microspheres—Fabrication, In Vitro & In Vivo Evaluation, Histological and Biochemical Analysis. MOJ Drug Des. Dev. Ther, (3): 1–10.
Kirubanandan S, Gokul D, Sehgal PK, 2008, Ciprofloxacin Loaded Gelatin Microspheres Impregnated Collagen Scaffold–An Effective Drug Delivery System for Infected Wound, 8th Asian Bioceramics Symposium, 142.
Kirubanandan S, 2017, Ciprofloxacin-Loaded Gelatin Microspheres Impregnated Collagen Scaffold for Augmentation of Infected Soft Tissue. Asian Journal of Pharmaceutics (AJP), 11(02): 1158.